Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Jun Ni, Yue Shang, Wen-die Wang, Chen Wang, Ai-min Wang, Gao-jie Li & Shu-zhen Chen. (2023) FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis
Through Upregulating PEPT1. Current Molecular Pharmacology 16:7.
Crossref
Crossref
Sarah A. Holstein, Caroline A. Heckman, Faith E. Davies, Gareth J. Morgan, Stefan Svensson Gelius & Fredrik Lehmann. (2023) Aminopeptidases in Cancer, Biology and Prospects for Pharmacological
Intervention. Current Cancer Drug Targets 23:1, pages 25-46.
Crossref
Crossref
Antonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte & Lucia Altucci. (2020) The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options. Cancers 12:7, pages 1898.
Crossref
Crossref
Karoline V. Gleixner, Irina Sadovnik, Mathias Schneeweiss, Gregor Eisenwort, Konstantin Byrgazov, Gabriele Stefanzl, Daniela Berger, Harald Herrmann, Emir Hadzijusufovic, Thomas Lion & Peter Valent. (2019) A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML. Leukemia Research 78, pages 36-44.
Crossref
Crossref
Felix Wolf, Franziska Leipoldt, Andreas Kulik, Daniel Wibberg, Jörn Kalinowski & Leonard Kaysser. (2018) Characterization of the Actinonin Biosynthetic Gene Cluster. ChemBioChem 19:11, pages 1189-1195.
Crossref
Crossref
MASAFUMI YAMASHITA, HIROSHI WADA, HIDETOSHI EGUCHI, HISATAKA OGAWA, DAISAKU YAMADA, TAKEHIRO NODA, TADAFUMI ASAOKA, KOICHI KAWAMOTO, KUNIHITO GOTOH, KOJI UMESHITA, YUICHIRO DOKI & MASAKI MORI. (2016) A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma. International Journal of Oncology 49:1, pages 89-98.
Crossref
Crossref
Xijun Qian, Jingsong He, Yi Zhao & Maofang Lin. (2016) Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells. American Journal of Therapeutics 23:3, pages e680-e689.
Crossref
Crossref
Li Wang, Changyuan Wang, Yongming Jia, Zhihao Liu, Xiaohong Shu & Kexin Liu. (2016) Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells. Journal of Cellular Biochemistry 117:5, pages 1233-1239.
Crossref
Crossref
Yanna Zhu, Qiang Meng, Changyuan Wang, Qi Liu, Xiaokui Huo, Aijie Zhang, Pengyuan Sun, Huijun Sun, Hua Li & Kexin Liu. (2014) Methotrexate-bestatin interaction: Involvement of P-glycoprotein and organic anion transporters in rats. International Journal of Pharmaceutics 465:1-2, pages 368-377.
Crossref
Crossref
Sarina M. Hitzerd, Sue Ellen Verbrugge, Gert Ossenkoppele, Gerrit Jansen & Godefridus J. Peters. (2014) Positioning of aminopeptidase inhibitors in next generation cancer therapy. Amino Acids 46:4, pages 793-808.
Crossref
Crossref
Xiaokui Huo, Qi Liu, Changyuan Wang, Qiang Meng, Huijun Sun, Jinyong Peng, Xiaochi Ma, Pengyuan Sun & Kexin Liu. (2014) Inhibitory Effect of Valsartan on the Intestinal Absorption and Renal Excretion of Bestatin in Rats. Journal of Pharmaceutical Sciences 103:2, pages 719-729.
Crossref
Crossref
Xiaokui Huo, Qi Liu, Changyuan Wang, Qiang Meng, Huijun Sun, Jinyong Peng, Xiaochi Ma & Kexin Liu. (2013) Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. European Journal of Pharmaceutical Sciences 50:3-4, pages 420-428.
Crossref
Crossref
Kai ZhangWei ChenYun ZhangYan GeSongwen JuPeng YangYongfei TanZhijun GeZhihong CaoYanpin ZhaoHaorong WuSongguang Ju. (2013) An Anti-Human CD13 Monoclonal Antibody That Suppresses the Suppressive Function of Treg Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 32:1, pages 16-20.
Crossref
Crossref
Wei‐Ching Huang, Cheng‐Chieh Tsai, Chia‐Ling Chen, Tsai‐Yun Chen, Ya‐Ping Chen, Yee‐Shin Lin, Pei‐Jung Lu, Chun‐Mao Lin, Shwu‐Huey Wang, Chiung‐Wen Tsao, Chi‐Yun Wang, Yi‐Lin Cheng, Chia‐Yuan Hsieh, Po‐Chun Tseng & Chiou‐Feng Lin. (2011) Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr‐Abl inhibitor and cooperatively induces glycogen synthase kinase‐3‐regulated apoptosis. The FASEB Journal 25:10, pages 3661-3673.
Crossref
Crossref
Shu-Xiang Cui, Xian-Jun Qu, Zu-Hua Gao, Yu-Sheng Zhang, Xiao-Fan Zhang, Cui-Rong Zhao, Wen-Fang Xu, Qian-Bin Li & Jin-Xiang Han. (2010) Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cancer Letters 292:2, pages 153-162.
Crossref
Crossref
Karoline V. Gleixner, Veronika Ferenc, Barbara Peter, Alexander Gruze, Renata A. Meyer, Emir Hadzijusufovic, Sabine Cerny-Reiterer, Matthias Mayerhofer, Winfried F. Pickl, Christian Sillaber & Peter Valent. (2010) Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536. Cancer Research 70:4, pages 1513-1523.
Crossref
Crossref
Meisong Lu, Lan Xiao, Jianli Hu, Suo Deng & Yan Xu. (2008) Targeting of p38 mitogen-activated protein kinases to early growth response gene 1 (EGR-1) in the human paclitaxel-resistance ovarian carcinoma cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 28:4, pages 451-455.
Crossref
Crossref
Marwan Alfalah, Michael P. Krahn, Gabi Wetzel, Stephan von Hörsten, Carmen Wolke, Nigel Hooper, Thomas Kalinski, Sabine Krueger, Hassan Y. Naim & Uwe Lendeckel. (2006) A Mutation in Aminopeptidase N (CD13) Isolated from a Patient Suffering from Leukemia Leads to an Arrest in the Endoplasmic Reticulum. Journal of Biological Chemistry 281:17, pages 11894-11900.
Crossref
Crossref
Brigitte Bauvois & Daniel Dauzonne. (2006) Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: Chemistry, biological evaluations, and therapeutic prospects. Medicinal Research Reviews 26:1, pages 88-130.
Crossref
Crossref
Mirjana Grujic, Tina Zavasnik-Bergant, Gunnar Pejler & Metka Renko. (2005) Actinonin induces apoptosis in U937 leukemia cells. Cancer Letters 223:2, pages 211-218.
Crossref
Crossref
Michael G. Kharas & David A. Fruman. (2005)
ABL
Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
. Cancer Research 65:6, pages 2047-2053.
Crossref
Crossref
HIROSHI FUJIWARA. (2004) Functional roles of cell surface peptidases in reproductive organs. Reproductive Medicine and Biology 3:4, pages 165-176.
Crossref
Crossref
Mona D. Lee, Yuhong She, Michael J. Soskis, Christopher P. Borella, Jeffrey R. Gardner, Paula A. Hayes, Benzon M. Dy, Mark L. Heaney, Mark R. Philips, William G. Bornmann, Francis M. Sirotnak & David A. Scheinberg. (2004) Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics. Journal of Clinical Investigation 114:8, pages 1107-1116.
Crossref
Crossref
Heiwa Kanamori, Hirotaka Takasaki, Maki Takabayashi, Satoshi Yamaji, Hideyuki Koharazawa, Katsumichi Fujimaki, Jun Taguchi & Yoshiaki Ishigatsubo. (2004) Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia. Anti-Cancer Drugs 15:7, pages 729-731.
Crossref
Crossref